Envista Holdings Corporation

NVST

US29415F1049

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 01:30:02 22/06/2024 am IST			5-day change	1st Jan Change
17.41 ^USD	+1.22%		-1.47%	-27.64%

30/05	Envista Holdings Corporation Announces Step Down of Eric Conley as Senior Vice President and President, Orthodontics, Effective June 3, 2024	CI
29/05	Transcript : Envista Holdings Corporation Presents at Stifel Jaws & Paws Conference, May-29-2024 04:10 PM

Envista Holdings Corporation Announces Step Down of Eric Conley as Senior Vice President and President, Orthodontics, Effective June 3, 2024

May 31, 2024 at 01:40 am IST

On May 27, 2024, Eric Conley notified Envista Holdings Corporation that he will step down as SVP and President, Orthodontics of the Company, effective June 3, 2024 to pursue another opportunity.

Latest news about Envista Holdings Corporation

Envista Holdings Corporation Announces Step Down of Eric Conley as Senior Vice President and President, Orthodontics, Effective June 3, 2024	31/05	CI
Transcript : Envista Holdings Corporation Presents at Stifel Jaws & Paws Conference, May-29-2024 04:10 PM	30/05
Bausch + Lomb's New Intraocular Lens Approved by Health Canada	28/05	MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Reports Q1 EPS $0.26, vs. Street Est of $0.32	02/05	MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q1 Revenue $623.6M, vs. Street Est of $634.5M	02/05	MT
Transcript : Envista Holdings Corporation, Q1 2024 Earnings Call, May 01, 2024	02/05
Envista Holdings Corporation Reports Earnings Results for the First Quarter Ended March 29, 2024	02/05	CI
North American Morning Briefing : Investors Brace -2-	29/04	DJ
Morgan Stanley Downgrades Envista Holdings to Equalweight From Overweight, Cuts Price Target to $21 From $33	26/04	MT
Envista Holdings Names Paul Keel as CEO	16/04	MT
Envista Holdings Corporation Announces Chief Executive Officer Changes	16/04	CI
Envista Holdings Corporation Announces Management Changes	16/04	CI
Bausch + Lomb to Present New Data and Analyses at American Society of Cataract and Refractive Surgery Annual Meeting	27/03	MT
Envista Holdings Starts CEO Succession Process	27/02	MT
Leerink Partners Initiates Envista Holdings at Underperform Rating With $19 Price Target	26/02	MT
North American Morning Briefing : Stock Futures -2-	12/02	DJ
UBS Adjusts Envista Holdings Price Target to $23 From $26, Maintains Neutral Rating	09/02	MT
Jefferies Downgrades Envista Holdings to Hold From Buy, Adjusts Price Target to $23 From $30	09/02	MT
North American Morning Briefing : Stock Futures -2-	09/02	DJ
William Blair Downgrades Envista Holdings to Market Perform From Outperform	08/02	MT
Sector Update: Health Care Stocks Steady Premarket Thursday	08/02	MT
Envista Holdings' Q4 Adjusted Earnings Fall, Revenue Rises; Shares Fall Pre-Bell	08/02	MT
Transcript : Envista Holdings Corporation, Q4 2023 Earnings Call, Feb 07, 2024	08/02
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 Revenue $645.6M, vs. Street Est of $638.4M	08/02	MT
Earnings Flash (NVST) ENVISTA HOLDINGS CORPORATION Posts Q4 EPS $0.29, vs. Street Est of $0.34	08/02	MT

Chart Envista Holdings Corporation

Duration

Period

More charts

Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.

Sector

Medical Equipment, Supplies & Distribution

Calendar

31/07/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Ratings for Envista Holdings Corporation

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

17.41 USD

Average target price

20.23 USD

Spread / Average Target

+16.18%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ENVISTA HOLDINGS CORPORATION	-27.64%	2.99B
ABBOTT LABORATORIES	-3.95%	184B
MEDTRONIC PLC	-0.90%	109B
BECTON, DICKINSON AND COMPANY	-2.27%	68.87B
CENCORA, INC.	+15.24%	46.61B
DEXCOM, INC.	-6.00%	46.39B
HOYA CORPORATION	+5.36%	40.74B
METTLER-TOLEDO INTERNATIONAL, INC.	+20.65%	31.26B
WEST PHARMACEUTICAL SERVICES, INC.	-5.50%	24.24B
TERUMO CORPORATION	+11.60%	24B

Other Medical Equipment, Supplies & Distribution